Tonix Pharmaceuticals Holding (TNXP) Assets
Market Cap: $122.56M
Avg Volume: 1.64M
Industry: Biotechnology
Sector: Healthcare
Tonix Pharmaceuticals Holding Asset Metrics Summary
According to Tonix Pharmaceuticals Holding's latest annual financial reports, the company's asset profile is as follows:
Total Assets
Tonix Pharmaceuticals Holding's total assets amount to $162.89M. This is divided into:
- Total Current Assets: $119.00M
- Total Non-current Assets: $43.89M
- Net Receivables: $8.08M
- Inventory: $8.41M
- Cash and Short-term Investments: $98.78M
- Property, Plant, and Equipment (Net): $42.82M
- Long-term Investments: $-
- Goodwill and Intangible Assets: $120.00K
Asset Ratios and Metrics
To better understand Tonix Pharmaceuticals Holding's asset management, we can look at several key ratios:
- Return on Assets (ROA): -79.83% - this indicates how profitable a company is relative to its total assets.
- Asset Turnover: 0.06 - this shows how efficiently a company uses its assets to generate sales.
- Current Ratio: 6.50 - this measures a company's ability to pay short-term obligations with its current assets.
- Quick Ratio: 6.04 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
- Cash Ratio: 5.40 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.
These metrics provide insight into Tonix Pharmaceuticals Holding's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.
Total Assets
$162.89M
Total Current Assets
$119.00M
Total Non-current Assets
$43.89M
Net Receivables
$8.08M
Inventory
$8.41M
Cash and Short-term Investments
$98.78M
Property, Plant, and Equipment (Net)
$42.82M
Long-term Investments
$-
Goodwill and Intangible Assets
$120.00K
Return on Assets
-79.83%
Asset Turnover
0.06
Current Ratio
6.50
Tonix Pharmaceuticals Holding Historical Asset Metrics
Historical Return on Assets
Historical Total Assets Growth
Tonix Pharmaceuticals Holding Historical Assets
The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Total Assets | Total Current Assets | Total Non-current Assets | Net Receivables | Inventory | Cash and Short-term Investments | Property, Plant, Equipment (Net) | Long-term Investments | Goodwill and Intangible Assets | Return on Assets | Asset Turnover | Current Ratio | Quick Ratio | Cash Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $162.89M | $119.00M | $43.89M | $8.08M | $8.41M | $98.78M | $42.82M | $- | $120.00K | -0.80 | 0.06 | 6.50 | 6.04 | 5.40 |
| 2023 | $154.46M | $47.77M | $106.69M | $4.59M | $14.15M | $24.95M | $94.85M | $- | $10.71M | -0.76 | 0.05 | 2.53 | 1.78 | 1.32 |
| 2022 | $225.69M | $130.78M | $94.91M | $- | $-8.04M | $120.23M | $94.53M | $241.00K | $120.00K | -0.52 | 0.00 | 7.19 | 7.64 | 6.61 |
| 2021 | $240.90M | $189.05M | $51.85M | $7.73M | $-7.73M | $178.66M | $51.47M | $240.00K | $120.00K | -0.38 | 0.00 | 8.71 | 9.06 | 8.23 |
| 2020 | $98.18M | $87.99M | $10.19M | $7.63M | $-7.63M | $77.07M | $9.83M | $240.00K | $120.00K | -0.53 | 0.00 | 8.96 | 9.74 | 7.85 |
| 2019 | $14.56M | $13.95M | $610.00K | $- | $-1.01M | $11.25M | $390.00K | $100.00K | $120.00K | -2.14 | 0.00 | 2.72 | 2.91 | 2.19 |
| 2018 | $26.32M | $26.06M | $263.00K | $- | $- | $25.03M | $43.00K | $100.00K | $120.00K | -1.12 | 0.00 | 9.81 | 9.81 | 9.43 |
| 2017 | $26.75M | $26.44M | $311.00K | $- | $- | $25.50M | $91.00K | $89.00K | $120.00K | -0.79 | 0.00 | 12.44 | 12.44 | 11.99 |
| 2016 | $27.51M | $27.14M | $370.00K | $- | $- | $26.12M | $150.00K | $89.00K | $120.00K | -1.41 | 0.00 | 12.83 | 12.83 | 8.95 |
| 2015 | $47.02M | $46.36M | $659.00K | $2.83M | $- | $43.02M | $350.00K | $189.00K | $120.00K | -1.02 | 0.00 | 6.97 | 6.97 | 2.88 |
Related Metrics
Explore detailed financial metrics and analysis for TNXP.